lifestyle.celebhomes.net
Home
Sample Page
Author:
Shanghai EpimAb Biotherapeutics Co., Ltd.
EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting
April 14, 2026
EpimAb Biotherapeutics Announces the First CTA Filing of a FIT-IG® Bispecific Antibody by its License Partner Almirall
February 10, 2026